Early research (Phase 1)Study completedNCT02186977What this trial is testingProof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-IDWho this might be right forHepatitis B Novosanis NV 48
Large-scale testing (Phase 3)UnknownNCT01270165What this trial is testingLamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BWho this might be right forChronic Hepatitis B Yonsei University 110
Early research (Phase 1)Study completedNCT02143401What this trial is testingNavitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forCirrhosisHepatitis B InfectionHepatitis C Infection+6 more National Cancer Institute (NCI) 29
Post-approval studies (Phase 4)UnknownNCT01833611What this trial is testingEntecavir for Chronic Hepatitis B Patients With Persistently Normal ALTWho this might be right forChronic Hepatitis National Cheng-Kung University Hospital 130
Testing effectiveness (Phase 2)Study completedNCT01106092What this trial is testingStudy to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy ToddlersWho this might be right forHaemophilus Influenzae Type bTetanusHepatitis B+3 more GlaxoSmithKline 312
Large-scale testing (Phase 3)Study completedNCT00410202What this trial is testingEntecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant VirusWho this might be right forHepatitis B, Chronic Bristol-Myers Squibb 629
Not applicableStudy completedNCT01813487What this trial is testingStudy of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110EWho this might be right forChronic Hepatitis B Genexine, Inc. 6
Not applicableStudy completedNCT00161941What this trial is testingFollow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216Who this might be right forMeningococcal Meninigitis, Serogroup C Pfizer 321
Not applicableUnknownNCT03539016What this trial is testingObservational Study on Pregnant Women With Chronic Hepatitis B and Their InfantsWho this might be right forHepatitis B, Chronic Nanfang Hospital, Southern Medical University 1,000
Testing effectiveness (Phase 2)Study completedNCT04365933What this trial is testingThe Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With EntecavirWho this might be right forHepatitis B, Chronic Enyo Pharma 20
Testing effectiveness (Phase 2)Study completedNCT03115736What this trial is testingTAF for HIV-HBV With Renal DysfunctionWho this might be right forHIV and Hepatitis B Coinfection Insel Gruppe AG, University Hospital Bern 24
Large-scale testing (Phase 3)Study completedNCT01340937What this trial is testingV419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)Who this might be right forBacterial InfectionsVirus Diseases Merck Sharp & Dohme LLC 2,808
Not applicableStudy completedNCT02025842What this trial is testingHepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaHepatitis B Azienda Ospedaliera San Camillo Forlanini 306
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294What this trial is testingStudy of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCCWho this might be right forHepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma Lion TCR Pte. Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT01457495What this trial is testingImmunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered ConcomitantlyWho this might be right forHepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more GlaxoSmithKline 312
Post-approval studies (Phase 4)Study completedNCT00657657What this trial is testingSafety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B VaccineWho this might be right forHepatitis B GlaxoSmithKline 29
Not applicableEnrolling By InvitationNCT07298577What this trial is testingUse of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver CancerWho this might be right forLiver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more Siriraj Hospital 2,100
Not applicableStudy completedNCT04032275What this trial is testingCorrelation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV InfectionWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 400
Testing effectiveness (Phase 2)Study completedNCT01943799What this trial is testingSafety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis BWho this might be right forChronic HBV Infection Gilead Sciences 178
Post-approval studies (Phase 4)Study completedNCT00356564What this trial is testingPersistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/HibWho this might be right forHepatitis B GlaxoSmithKline 350